Mangoceuticals (MGRX) Capital Expenditures (2023)
Mangoceuticals' (MGRX) quarterly Capital Expenditures came in at $3519.0 in Q1 2023.
Mangoceuticals (MGRX) Capital Expenditures (2023) Analysis & Trends
Mangoceuticals has disclosed Capital Expenditures across 1 years of filings, most recently posting $3519.0 for Q1 2023.
- Capital Expenditures for Q1 2023 came in at $3519.0, changed N/A year-over-year; the trailing twelve-month figure through Dec 2023 was $3519.0 (changed N/A YoY), and the FY2023 annual result was $3519.0, changed N/A from the prior year.
- Capital Expenditures came in at $3519.0 for Q1 2023 at Mangoceuticals.
- In the past five years, Capital Expenditures ranged from a high of $3519.0 in Q1 2023 to a low of $3519.0 in Q1 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 24.83 Bn | 17.52 Bn | 662.02 Mn | 1.75 Mn |
| 2 | BrightSpring Health Services | 13.57 Bn | 12.69 Bn | 482.22 Mn | 3.67 Mn |
| 3 | Healthequity | 7.20 Bn | 6.93 Bn | 256.31 Mn | 15.93 Mn |
| 4 | Hinge Health | 5.42 Bn | 5.11 Bn | 154.23 Mn | 28,000.00 |
| 5 | 10x Genomics | 4.46 Bn | 3.92 Bn | 106.18 Mn | 118,000.00 |
| 6 | Doximity | 3.81 Bn | 3.06 Bn | 125.97 Mn | 2.25 Mn |
| 7 | Waystar Holding | 3.52 Bn | 3.36 Bn | 268.04 Mn | 15.33 Mn |
| 8 | Privia Health | 2.94 Bn | 2.57 Bn | 595.71 Mn | - |
| 9 | Omnicell | 1.76 Bn | 1.59 Bn | 140.36 Mn | 12.44 Mn |
| 10 | Mangoceuticals | 5.25 Mn | 5.06 Mn | 29,001.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | 3,519.00 |
| Mar 31, 2023 | 3,519.00 |